Thank you, Chair.
Mr. Thiel, I'll start with you, and because I want to get to Mr. Smith, I want to package just two questions into it.
You made mention in your opening statement that you want to see the elimination of duplication in federal departments. Can you provide the committee with a few concrete examples of where that might exist?
With regard to my second question, Bayer is very much a global player. You have offices, and your reach extends, in many different countries. I previously had a phone call with the Canadian Seed Growers' Association. They mentioned that France and Portugal were two countries that were very forward looking in looking for future opportunities in innovation, seed development, and so on.
Can you provide this committee with any examples of countries we could be looking to as examples of technology and innovation, given that Bayer has such a global reach?